由 Coinbase CEO Brian Armstrong 联合创立的 NewLimit，正在 Yamanaka 因子之外寻找一类新型抗衰老药物。为何它入选 Endpoints 11：https://endpoints.news/endpoints-11-2026-winner-newlimit-searches-for-a-new-class-of-anti-aging-drugs/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial&utm_content= 错过了颁奖典礼？今年获奖者的精彩片段和采访可免费点播观看。
Co-founded by Coinbase CEO Brian Armstrong, NewLimit is hunting beyond the Yamanaka factors for a new class of anti-aging drugs. Why it made the Endpoints 11: https://endpoints.news/endpoints-11-2026-winner-newlimit-searches-for-a-new-class-of-anti-aging-drugs/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial&utm_content=
Missed the gala? Highlights and interviews with this year's honorees are available on demand, free.
来源：Endpoints News · x.com